姓名:陳穎 | |||
職稱:教授(碩導(dǎo)) | |||
辦公電話:0373-3326340 | |||
電子郵箱:[email protected] | |||
個(gè)人簡介: |
2020.4-至今 河南師范大學(xué) 生命科學(xué)學(xué)院 教授 2016.11-2017.12 美國科羅拉多大學(xué)安舒茨醫(yī)學(xué)院訪問學(xué)者 2015.2-2020.3 河南師范大學(xué) 生命科學(xué)學(xué)院 副教授 2007.07-2015.01 河南科技學(xué)院生命科技學(xué)院 副教授 2003.9-2006.6 山東大學(xué) 細(xì)胞生物學(xué)專業(yè) 博士學(xué)位 2000.9-2003.7 河南師范大學(xué) 動(dòng)物學(xué)專業(yè) 碩士學(xué)位 主要從事腦血管疾病的發(fā)病機(jī)制及天然活性物質(zhì)干預(yù)研究,。主持國家自然科學(xué)基金、河南省自然科學(xué)基金及基礎(chǔ)與前沿技術(shù)等多項(xiàng)研究工作,,在《Mol Neurobiology》,、《Food & Function》、《Journal of Functional Foods》等雜志發(fā)表學(xué)術(shù)研究論文20余篇,,其中SCI源期刊10余篇,,一區(qū)3篇,,二區(qū)1篇,,《Food & Function》和《Frontiers in Neuroscience》審稿人,,授權(quán)國家專利3項(xiàng),優(yōu)秀學(xué)術(shù)論文獎(jiǎng)4項(xiàng),。河南省教學(xué)技能比賽一等獎(jiǎng),,獲得河南省教學(xué)標(biāo)兵稱號(hào)。 |
研究領(lǐng)域: |
1.線粒體在腦血管疾病發(fā)生中的作用,; 2.天然活性產(chǎn)物藥理分子基礎(chǔ),; 3.納米載體藥物遞送。 |
主要學(xué)術(shù)及社會(huì)兼職: |
中國細(xì)胞生物學(xué)學(xué)會(huì)會(huì)員 |
主持或參加科研項(xiàng)目情況: |
1. EGCG基于S100A10對蛛網(wǎng)膜下腔出血后白質(zhì)損傷的保護(hù)機(jī)制研究(HNSJXF-2021-007),,河南省神經(jīng)修復(fù)重點(diǎn)實(shí)驗(yàn)室開放課題,,2022.01-2023.12,主持 2. 基于67LR探討miR-29a-3p/整合素β1介導(dǎo)的EGCG干預(yù)蛛網(wǎng)膜下腔出血后神經(jīng)功能損傷的機(jī)制研究(182300410299),,河南省自然科學(xué)基金,,2018.01-2019.12,,主持 3. EGCG 受體在星形膠質(zhì)細(xì)胞中的確證及其跨膜作用機(jī)制研究(31200519),,國家自然科學(xué)基金,2013.01-2015.12, 主持 4. 67LamR介導(dǎo)的EGCG神經(jīng)保護(hù)功能研究,,河南省基礎(chǔ)與前言技術(shù)研究計(jì)劃,,2013.01-2015.12,主持 5. 食品質(zhì)量與安全,,河南省高??萍紕?chuàng)新團(tuán)隊(duì),,2015.01-2017.12,參與 |
學(xué)術(shù)成果: |
代表性論文: 1. Chen Y*, Huang LY, Zhang HY, Diao XL, Zhao SY, Zhou WK. Reduction in autophagy by (-)-Epigallocatechin-3-3Gallate (EGCG): a potential mechanism of prevention of mitochondrial dysfunction after subarachnoid hemorrhage. Mol Neurobiol2017, 54(1): 392-405. (二區(qū) IF 6.19) 2. Chen Y*, Chen JJ, Sun XX, Shi XX, Wang L, Huang LY, Zhou WK. Evaluation ofthe neuroprotective effect of EGCG: a potential mechanism of mitochondrial dysfunction and mitochondrial dynamics after subarachnoid hemorrhage. Food Funct 2018, 9(12): 6349-6359. (一區(qū)) 3. Chen Y*, Huang LY, Wang L, Chen LY, Ren WH, Zhou WK. Differential expression of microRNAs contributed to the health efficacy of EGCG in in vitro subarachnoid hemorrhage model. Food Funct 2017, 8: 4675-4683. (一區(qū)) 4. Chen Y*, Huang LY, Zhang HY, Sun HY, Zhou WK. EGCG protective mitochondrial dysfunction after subarachnoid haemorrhage via inhibition p38α pathway. J Funct Foods 2016, 23: 115-123. (一區(qū)) 5. Zhang YY, Han MG, Sun XX, Gao GJ, Yu GY, Huang LY, Chen Y*. EGCG promotes neurite outgrowth through the integrin β1/FAK/p38 signaling pathway after subarachnoid hemorrhage. Evid Based Complement Alternat Med 2021, 2021:8810414. 6. Miao YH,Sun XX, Gao GJ, Jia XL, Wu H, Chen Y, Huang LY. Evaluation of(-)-epigallocatechin-3-gallate (EGCG)-induced cytotoxicity on astrocytes: A potential mechanism of calcium overloading-induced mitochondrial dysfunction.Toxicology in Vitro 2019, 61: 104592. 7. Huang LY,,Hou YQ,Wang L, Xu XH, Guan QK, Li XS, Chen Y, Zhou WK*. p38 inhibitor protects mitochondrial dysfunction by induction of DJ-1 mitochondrial translocation after subarachnoid hemorrhage. J Mol Neurosci 2018, 66(2): 163-171. 8. Chen Y, Sun HY, Huang LY*, Li JX, Zhou WK, Chang JL.Neuroprotective effect of radix trichosanthis saponins on subarachnoid hemorrhage. Evid Based Complement Alternat Med 2015, 2015: 313657. 9. Chen Y, Miao YH, Huang LY, Li JX, Sun HY, Zhao YZ, Yang J, Zhou WK. Antioxidant activities of saponins extracted from Radix Trichosanthis: an in vivo and invitro evaluation. BMC Complem Altern M 2014, 14: 86. 10. Chen Y, Zhang HY, Yang J, Sun HY. Improved antioxidant capacity of optimization of a self-microemulsifying drug delivery system for resveratrol. Molecules 2015, 20: 21167-21177. 11. Mo HZ,Chen Y*, Huang LY, Zhang H, Li JX, Zhou WK. Neuroprotective effect of tea polyphenols on oxyhemoglobin induced subarachnoid hemorrhage in mice.Oxid Med Cell Longe 2013, 2013: 743938. 12. Huang LY, Wan J, Chen Y, Wang ZW, Hui L, Li Y, Xu DW, Zhou WK*. Inhibitory effects of p38 inhibitor against mitochondrial dysfunction after subarachnoid hemorrhage in mice. Brain Res2013, 1517: 133-140. 13. Chen YH, Chen Y, Huang LY, Yu JB. Evaluation of heparanase and matrix metalloproteinase-9 in patients with cutaneous malignant melanoma. J Dermatol 2012, 39: 339-343. 14. Zhang HY, Chen Y, Fan BL, Wang WF, Zhu WL. Overexpression of VEGF183 promotes murine breast cancer cell proliferation in vitro and induces dilated intratumoral microvessels. Tumor Biol 2015, 36: 3871-3880. 專利成果: 1. 從天花粉中綜合提取多種生物活性成分的方法,,國家發(fā)明專利(授權(quán)),ZL201410291925.6 2. 天花粉皂苷及其在制備治療缺血性腦血管疾病中的應(yīng)用,,國家發(fā)明專利(授權(quán)),,ZL201010537400.8 3. 抗癌藥物組合物,國家發(fā)明專利(授權(quán)),,ZL2004100359256 |